Basit öğe kaydını göster

dc.contributor.authorErdem, H.
dc.contributor.authorKilic, S.
dc.contributor.authorCoskun, O.
dc.contributor.authorErsoy, Y.
dc.contributor.authorCagatay, A.
dc.contributor.authorOnguru, P.
dc.contributor.authorAlp, S.
dc.date.accessioned2019-12-10T11:11:08Z
dc.date.available2019-12-10T11:11:08Z
dc.date.issued2010
dc.identifier.issn1198-743X
dc.identifier.urihttps://doi.org/10.1111/j.1469-0691.2009.03039.x
dc.identifier.urihttp://hdl.handle.net/11655/14949
dc.description.abstractP>This investigation aimed both to delineate the current status of community-acquired acute bacterial meningitis and to produce data on the interrelationships between clinical, laboratory and therapeutic parameters in the elderly. This retrospective cohort study was conducted in 28 Turkish institutions in 159 culture-positive patients over the age of 50 years. Streptococcus pneumoniae was the most common pathogen (69.2%), followed by Listeria monocytogenes (8.8%). For this reason, antilisterial antibiotics such as ampicillin or benzylpenicillin should be added to the therapeutic regimen. Pathogen-specific mortality did not vary between S. pneumoniae and L. monocytogenes. The overall mortality was 2.5% at the third day, 12.6% at the seventh day, 20.1% at the 14th day and 21.4% at the 21st day. The risk factors for fatality were increasing age, the presence of stupor, sepsis and inappropriate antibiotic administration. Cerebrospinal fluid (CSF) leukocyte counts and CSF/blood glucose ratios were lower in patients who died. Fever did not differ between survivors and fatal cases. The mean duration of antibiotic therapy in survivors was 16.3 +/- 6.4 days. One-fifth of the patients had complications, and in 5.7% of the patients sequelae persisted at follow-up.
dc.language.isoen
dc.publisherElsevier Sci Ltd
dc.relation.isversionof10.1111/j.1469-0691.2009.03039.x
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectInfectious Diseases
dc.subjectMicrobiology
dc.titleCommunity-Acquired Acute Bacterial Meningitis In The Elderly In Turkey
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalClinical Microbiology And Infection
dc.contributor.departmentİç Hastalıkları
dc.identifier.volume16
dc.identifier.issue8
dc.identifier.startpage1223
dc.identifier.endpage1229
dc.description.indexWoS
dc.description.indexScopus


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster